Skip to Content

Lannett 1782 250 mg (Temozolomide 250 mg)

Pill with imprint Lannett 1782 250 mg is White, Capsule-shape and has been identified as Temozolomide 250 mg. It is supplied by Lannett Company, Inc..

Temozolomide is used in the treatment of glioblastoma multiforme; anaplastic astrocytoma; anaplastic oligodendroglioma; melanoma, metastatic; melanoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lannett 1782 250 mg

Temozolomide

Imprint:
Lannett 1782 250 mg
Strength:
250 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Alkylating agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Lannett Company, Inc.
National Drug Code (NDC):
00527-1782

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide